Original articles
Acetoacetate and β-Hydroxybutyrate Differentially Regulate Endothelin-1 and Vascular Endothelial Growth Factor in Mouse Brain Microvascular Endothelial Cells

https://doi.org/10.1016/S1056-8727(99)00030-6Get rights and content

Abstract

Insulin-dependent diabetes mellitus (IDDM), is characterized by a lack of insulin production from β cells in the pancreas. One of the metabolic consequences of this insulin deficit is an increased hepatic synthesis of ketone bodies, resulting in a serious medical complication, diabetic ketoacidosis (DKA). DKA, in turn, has been associated with the development of cerebral edema. The severity of this complication ranges from death to a subclinical presentation, but seems to be invariably present to some degree. The etiology of the cerebral edema is unknown, but changes in osmolality, pH, and insulin effects on the blood–brain barrier have all been suggested as possible culprits. Blood–brain barrier impermeability is maintained by the endothelial cells (EC) lining the blood vessels. Thus, it would seem likely that alterations in EC function would be necessary for the development of cerebral edema. However, no studies have examined the effects of ketone bodies on brain endothelial cells. The two major ketone bodies in DKA are acetoacetate (AcAc) and β-hydroxybutyrate (BOHB). In the present study we examined the effect of these ketone bodies on a major intracellular signalling pathway. The changes in intracellular calcium concentration, and the production of two vasoactive peptides, endothelin-1 (ET-1) and vascular permeability factor (VPF/VEGF) in mouse brain microvascular endothelial cells (MBMEC). The present studies demonstrate the BOHB can increase vascular permeability factor. In contrast, AcAc increases the production of the potent vasoconstrictor, endothelin-1. This data would suggest that brain ECs are potential targets of the metabolic alterations in DKA.

Introduction

The metabolic crisis of diabetic ketoacidosis (DKA) can result in the well-recognized, life-threatening, acute complication of brain edema in children and adolescents. There is good evidence that this complication also occurs in a subclinical form in a large percentage of patients, and it is very likely present in some patients even prior to the initiation of DKA treatment.1, 2

The pathogenesis of the brain edema is uncertain, but several theories have been proposed. The most commonly cited theories are (1) a rapid decrease in the plasma osmolality; (2) a disequilibrium between intra- and extracellular pH; (3) an insulin effect on the blood–brain barrier; and/or (4) vasopressin-mediated water retention. These theories suggest that the treatment of the hyperosmolar state and/or the ketoacidosis play a major role in this complication, but the theories do not explain the presence of edema prior to treatment, nor do they address whether the site of the initial insult is vascular (vasogenic) or cellular (cytotoxic).3

We have reported an inverse correlation between the degree of acidosis and the pretreatment presence of brain edema, and a direct correlation between the degree of hyperglycemia and the pretreatment presence of brain edema.2 Therefore, it would seem that the metabolic alterations associated with DKA (ketone bodies, low pH, hyperglycemia and hyperosmolality) would be putative initiators. Koya and King4 also recently reviewed the potential pathways whereby activation of protein kinase C by hyperglycemia may increase vascular permeability. The hyperketonemia and acidosis seen in DKA are the result of increased levels of both acetoacetate (AcAc) and β-hydroxybutyrate (βOHB), with molar concentrations in the blood sometimes being increased over 30-fold.5 Initially, βOHB exceeds AcAc by a ratio of 3:1, possibly due to a selective defect in βOHB utilization;6 but the ratio of βOHB to AcAc gradually decreases during the treatment of DKA.7

Blood–brain barrier integrity is maintained by the endothelial cells (EC) lining the cerebral blood vessels, and thus would be a logical target in any condition leading to brain edema. In order to determine if the brain endothelial cells are a target of ketone bodies, we examined the effects of AcAc and βOHB on the production of vascular permeability factor/vascular endothelial growth factor (VEGF)8 and endothelin-1 (ET-1)9, 10—two peptides important in endothelial cell function and known to be involved in edema formation in the brain.11, 12

Section snippets

Endothelial Cell Culture

Primary mouse brain microvascular endothelial cells (MBMEC) were purchased from In Vitrocyte (Seattle, WA) and used at passages 3–6 for these studies. MBMEC were purified by their ability to metabolize fluorescently labeled, acetylated, low-density lipoprotein (DiI-Ac-LDL), and were examined by their ability to bind to griffonia simplicifolia agglutinin (GSA). Cells were grown to confluence in MBMEC growth medium (Cell Applications, San Diego, CA), supplemented with 10% fetal calf serum (v:v)

Results

Figure 1A–F shows the increase in intracellular calcium in MBMEC to varying concentrations (1–100 nM) of either βOHB and AcAc. In contrast, further increases in the concentrations of either ketone body (up to 100 mM) had no further effect on intracellular calcium. In additional experiments, ketone bodies in medium in which the pH was adjusted between 6.8 and 7.8 were found to have no additional effect on intracellular calcium (data not shown). In separate experiments, MBMEC were grown in a high

Discussion

The relationship between ketone bodies and brain metabolism is well documented in DKA,15 with βOHB and AcAc crossing the blood–brain barrier via a monocarboxylic acid transport system.16 This transport is influenced by increased blood concentrations of ketone bodies and utilized in a region-specific pattern.17 This is supported by more recent studies where proton MR spectroscopy of the brain has demonstrated ketone bodies during treatment of DKA.18 There is clinical data to suggest that the

References (37)

  • R. Nosadini et al.

    Acetoacetate and B-hydroxybutyrate kinetics in obese and insulin-dependent diabetic humans

    Am J Physiol

    (1985)
  • J.M. Stephens et al.

    Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes

    Diabetes

    (1971)
  • D.T. Connolly

    Vascular permeability factorA unique regulator of blood vessel function

    J Cell Biochem

    (1991)
  • N. Ferrara et al.

    Molecular and biological properties of the vascular endothelial growth factor family of proteins

    Endo Rev

    (1992)
  • E.R. Levin

    Endothelins

    N Engl J Med

    (1995)
  • W. Wang et al.

    Vascular endothelial growth factor affects permeability of brain mocrovessel endothelial cells in vitro

    Am J Physiol

    (1996)
  • G. Gartshore et al.

    Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia

    Exp Neurol

    (1997)
  • H. Rasmussen et al.

    Diacyglycerol production; Ca 2+ influx, and protein kinase C activation in sustained cellular responses

    Endocr Rev

    (1995)
  • Cited by (71)

    • Metabolomics comparison of cord and peripheral blood-derived serum eye drops for the treatment of dry eye disease

      2021, Transfusion and Apheresis Science
      Citation Excerpt :

      Interestingly, β-hydroxybutyrate seems to be effective also for the treatment of tear-deficiency in a placebo-controlled study on 65 DED patients [37]. β-hydroxybutyrate stimulates the synthesis of VEGF [38], which is also more concentrated in CBS than in PBS [14]. Another metabolite significantly enriched in CBS is myo-inositol, which has important roles during pregnancy promoting cellular proliferation and organ development [39].

    • Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis

      2019, Experimental and Molecular Pathology
      Citation Excerpt :

      Recent publications by Woo et al. (2016b) and by Garro et al. (2017) reported a positive correlation between DKA severity and the prevalence of MMP8 and MMP9, and hypothesized that these enzymes are playing a role in the disruption of the blood-brain barrier by extracellular matrix cleavage. Activation of MMP9 before DKA treatment likely involves: hyperglycemia, ketones, methylglyoxal and endothelin 1 (ET-1) (Isales et al., 1999; Kim et al., 2012; Koyama et al., 2017); hypercortisolemia and free fatty acids (Boden and Song, 2008), in addition to the bidirectional modulation by inflammatory cytokines and chemokines (Strazielle et al., 2003), whose cleavage by MMP9 can result in a gain of function of some substrates (Van Lint and Libert, 2007). Also, of potential importance is that insulin has been reported to activate MMP9 (Fedorova et al., 2018).

    • The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management

      2016, Metabolism: Clinical and Experimental
      Citation Excerpt :

      The high H + level allows more Na + into the cell, which attracts water into the cell leading to edema [136]. The ketone bodies acetoacetate and β-hydoxybutyrate may also play a role in the pathogenesis of cerebral edema [137]. Ketone bodies have been shown to affect vascular integrity and permeability and contribute to edema formation.

    • The Impact of Diabetes on Brain Function in Childhood and Adolescence

      2015, Pediatric Clinics of North America
      Citation Excerpt :

      In periods of sustained insulinopenia or energy restriction, ketone bodies can serve as the primary cerebral energy source, providing up to 60% of metabolic requirements.53 Ketone bodies can also have direct influences on brain activity by causing increased levels of vascular permeability factor and the vasoconstrictor endothelin-1.54 In vivo animal studies have shown both benefits and injury to the brain from excessive ketosis, which are again related to context.

    View all citing articles on Scopus
    View full text